TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MIRM

Mirum Pharmaceuticals Inc

Healthcare · Biotechnology

89.40$ +0.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement MIRM
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – +74.0% +302.7% +141.8% +80.8% +54.7%
– – +92.3% +205.5% +550.2% +280.1% +73.6% +23.2%
– – – – +275.3% +115.4% +83.2% +64.8%
– +1,744.3% +89.8% +61.1% -18.7% -4.0% +37.1% +32.4%
– +1,239.3% +93.1% +120.4% -66.1% +723.1% +36.6% +34.8%
– +1,777.3% +89.4% +83.9% +2.8% +26.8% +38.0% +29.3%
– – – – – – – –
– – -86.8% +5,150.7% -9.2% -5.5% -5.3% +0.5%
– – – – – – – –
– – -71.4% +516.7% -17,413.5% – +3.9% +88.0%
– – – – – – – –
– – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?